Viewing Study NCT00216567


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2026-04-11 @ 8:28 PM
Study NCT ID: NCT00216567
Status: COMPLETED
Last Update Posted: 2011-02-01
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy
Sponsor: Janssen Korea, Ltd., Korea
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CR005077
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators